Sol-Gel Technologies Ltd. (SLGL) Financial Ratios
12 years of historical data (2014–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: 448.86
P/FCF
704.54
↑+65% vs avg
5yr avg: 426.90
P/B Ratio
↓
8.49
↓-46% vs avg
5yr avg: 15.65
30Y Low5.1·High63.9
ROE
↓
-23.7%
↓+19% vs avg
5yr avg: -29.4%
30Y Low-67%·High6%
Debt/EBITDA
N/A
—
5yr avg: 0.41
30Y Low0.1·High0.4
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
SLGL Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Sol-Gel Technologies Ltd. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 704.5x P/FCF, 65% above the 5-year average of 426.9x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $194M | $117M | $259M | $301M | $1.1B | $1.7B | $2.2B | $3.4B | $1.1B | — | — |
| Enterprise Value | $184M | $107M | $241M | $295M | $1.0B | $1.7B | $2.2B | $3.3B | $1.1B | — | — |
| P/E Ratio → | -31.61 | — | — | — | — | 528.57 | — | — | — | — | — |
| P/S Ratio | 9.99 | 6.06 | 22.45 | 193.48 | 271.61 | 55.77 | 251.97 | 146.27 | 8338.21 | — | — |
| P/B Ratio | 8.49 | 5.15 | 8.98 | 7.78 | 24.98 | 31.37 | 43.46 | 63.86 | 16.83 | — | — |
| P/FCF | 704.54 | 426.90 | — | — | — | — | — | — | — | — | — |
| P/OCF | 601.71 | 364.59 | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
SLGL EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 5.54 | 20.88 | 189.71 | 268.61 | 55.17 | 251.39 | 145.95 | 8296.93 | — | — |
| EV / EBITDA | — | — | — | — | — | 448.86 | — | 124.56 | — | — | — |
| EV / EBIT | — | — | — | — | — | 582.12 | — | — | — | — | — |
| EV / FCF | — | 390.38 | — | — | — | — | — | — | — | — | — |
SLGL Profitability
Margins and return-on-capital ratios measuring operating efficiency
Sol-Gel Technologies Ltd. earns an operating margin of -39.2%. Operating margins have expanded from -1885.8% to -39.2% over the past 3 years, signaling improving operational efficiency. A negative ROE of -23.7% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 99.4% | 99.4% | 98.0% | -1414.9% | -226.6% | 34.8% | -218.2% | -77.2% | -21718.6% | -72.4% | — |
| Operating Margin | -39.2% | -39.2% | -104.1% | -1885.8% | -418.3% | 9.5% | -344.7% | 113.3% | -25985.3% | -18179.9% | — |
| Net Profit Margin | -31.6% | -31.6% | -91.7% | -1752.8% | -384.3% | 10.3% | -333.9% | -107.4% | -24963.6% | -18142.5% | — |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -23.7% | -23.7% | -31.4% | -67.4% | -30.5% | 6.1% | -56.7% | -42.3% | -574.5% | — | — |
| ROA | -18.6% | -18.6% | -26.1% | -59.3% | -25.8% | 5.0% | -48.6% | -37.6% | -75.8% | -240.1% | -216.0% |
| ROIC | -48.6% | -48.6% | -41.5% | -69.4% | -36.0% | 5.4% | -49.9% | 37.5% | -76.0% | -717.3% | — |
| ROCE | -28.0% | -28.0% | -33.7% | -69.7% | -32.2% | 5.4% | -56.0% | 43.4% | -519.8% | — | — |
SLGL Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $11M exceeds total debt of $991000, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.04 | 0.04 | 0.05 | 0.04 | 0.02 | 0.03 | 0.04 | 0.04 | — | — | — |
| Debt / EBITDA | — | — | — | — | — | 0.41 | — | 0.08 | — | — | — |
| Net Debt / Equity | — | -0.44 | -0.63 | -0.15 | -0.28 | -0.33 | -0.10 | -0.14 | -0.08 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | -4.81 | — | -0.27 | — | — | — |
| Debt / FCF | — | -36.52 | — | — | — | — | — | — | — | — | — |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — |
Net cash position: cash ($11M) exceeds total debt ($991000)
SLGL Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Sol-Gel Technologies Ltd.'s current ratio of 4.37x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 9.10x to 4.37x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.37 | 4.37 | 5.92 | 9.10 | 12.93 | 4.88 | 8.95 | 8.58 | 13.48 | 0.16 | 0.20 |
| Quick Ratio | 4.37 | 4.37 | 5.92 | 9.10 | 12.93 | 4.88 | 8.95 | 8.58 | 13.48 | 0.16 | 0.20 |
| Cash Ratio | 3.89 | 3.89 | 4.53 | 8.40 | 10.10 | 3.70 | 8.41 | 7.74 | 12.87 | 0.13 | 0.17 |
| Asset Turnover | — | 0.65 | 0.32 | 0.03 | 0.08 | 0.45 | 0.15 | 0.37 | 0.00 | 0.01 | — |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 37.05 | 113.73 | 88.55 | 744.48 | 152.49 | 89.60 | 65.66 | — | — | — |
SLGL Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Sol-Gel Technologies Ltd. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | 0.2% | — | — | — | — | — |
| FCF Yield | 0.1% | 0.2% | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $3M | $28M | $27M | $23M | $24M | $23M | $20M | $18M | $18M | $12M |
Peer Comparison
Compare SLGL with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 SLGLYou | $194M | -31.6 | — | 704.5 | 99.4% | -39.2% | -23.7% | -48.6% | — |
 DERM | $102M | -6.9 | — | — | 62.8% | -24.4% | -72.6% | -56.8% | — |
 PRGO | $2B | -1.1 | 7.4 | 11.1 | 35.1% | 8.1% | -39.3% | 3.7% | 5.8 |
 VYNE | $29M | -1.1 | — | — | 96.0% | -5219.1% | -66.3% | -124.0% | — |
 SKIN | $118M | -5.7 | 7331.2 | 3.2 | 65.3% | -6.9% | -16.8% | -6.8% | 10519.4 |
 GDRX | $973M | 33.3 | 4.0 | 5.9 | 82.1% | 13.4% | 4.5% | 13.0% | 0.3 |
 NKTR | $2B | -8.6 | — | — | 100.0% | -236.8% | -217.9% | -57.2% | — |
 PODD | $11B | 46.1 | 19.8 | 29.8 | 71.6% | 17.5% | 18.1% | 20.1% | 1.8 |
 PAHC | $2B | 36.3 | 15.7 | 41.8 | 30.9% | 8.5% | 17.8% | 9.8% | 4.9 |
 ACRS | $586M | -9.2 | — | — | 73.3% | -975.9% | -50.2% | -53.5% | — |
 DARE | $25M | -6.1 | — | 5.3 | -146110.2% | -239692.2% | — | — | — |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 12 years · Updated daily
See SLGL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SLGL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SLGL vs DERM
Side-by-side business, growth, and profitability comparison vs Journey Medical Corporation.
Start ComparisonSLGL — Frequently Asked Questions
Quick answers to the most common questions about buying SLGL stock.
What is Sol-Gel Technologies Ltd.'s P/E ratio?
Sol-Gel Technologies Ltd.'s current P/E ratio is -31.6x. This places it at the 50th percentile of its historical range.
What is Sol-Gel Technologies Ltd.'s ROE?
Sol-Gel Technologies Ltd.'s return on equity (ROE) is -23.7%. The historical average is -35.1%.
Is SLGL stock overvalued?
Based on historical data, Sol-Gel Technologies Ltd. is trading at a P/E of -31.6x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Sol-Gel Technologies Ltd.'s profit margins?
Sol-Gel Technologies Ltd. has 99.4% gross margin and -39.2% operating margin.